19
Jun
2024

ESPEE GROUP

Exhibitor at CPHI & PMEC China 2024 stand E1D10, Pharma Ingredients
About Us

Espee Group - Reinventing Healthcare - Legacy of more than 35 years having 2 Business Verticals - Manufacturing and Services:
 Manufacturing:

 Group currently has 1 USFDA & DEA approved Oral Solid Manufacturing Plant in Atlanta, USA. Total of 12 ANDA filed and under development. 
2 USFDA approved, API ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2017
    On CPHI since
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand E1D10, Pharma Ingredients

Products Featured at CPHI & PMEC China 2024

  • Custom Synthesis And Contract Manufacturing Service

    Product Custom Synthesis And Contract Manufacturing Service

    Espee Group offers wide range of services which includes custom synthesis and contract manufacturing service. It aims at providing customized services and solutions with economical and timely execution of the projects and for starting materials, intermediaries and active ingredients. Its business model is ...
  • Reference Listed Drugs (Rlds) Or Innovator Products Sample Service

    Product Reference Listed Drugs (Rlds) Or Innovator Products Sample Service

    Espee Group offers wide range of services which includes reference listed drugs (rlds) or innovator products sample service. Its experience as pharmaceutical distributors combined with the international network of pharmaceutical drug wholesaler partners make it leader in the industry. Direct relationships ...
  • Regulatory And Marketing Support Service

    Product Regulatory And Marketing Support Service

    Espee Group offers wide range of services which includes regulatory and marketing support service. It is a dedicated quality assurance and regulatory affairs support is part of the its group. It aim for highest possible quality, efficacy and safety of pharmaceutical products in the markets in which it is p...